September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Blockade of NOX2 or arginase prevents diabetes-induced retinal endothelial cell senescence by restoring NO bioavailability
Author Affiliations & Notes
  • Modesto Rojas
    Vascular Biology Center, Augusta University, Augusta, Georgia, United States
    Research, Veterans Affairs Medical Center, Augusta, Georgia, United States
  • Tahira Lemtalsi
    Vascular Biology Center, Augusta University, Augusta, Georgia, United States
    Research, Veterans Affairs Medical Center, Augusta, Georgia, United States
  • Haroldo A Toque
    Pharmacology and Toxicology, Augusta University, Augusta, Georgia, United States
  • Zhimin Xu
    Vascular Biology Center, Augusta University, Augusta, Georgia, United States
    Research, Veterans Affairs Medical Center, Augusta, Georgia, United States
  • Esraa Shosha
    Vascular Biology Center, Augusta University, Augusta, Georgia, United States
    Research, Veterans Affairs Medical Center, Augusta, Georgia, United States
  • David Fulton
    Vascular Biology Center, Augusta University, Augusta, Georgia, United States
  • R. William Caldwell
    Pharmacology and Toxicology, Augusta University, Augusta, Georgia, United States
  • Ruth B Caldwell
    Vascular Biology Center, Augusta University, Augusta, Georgia, United States
    Research, Veterans Affairs Medical Center, Augusta, Georgia, United States
  • Footnotes
    Commercial Relationships   Modesto Rojas, None; Tahira Lemtalsi, None; Haroldo Toque, None; Zhimin Xu, None; Esraa Shosha, None; David Fulton, None; R. William Caldwell, None; Ruth Caldwell, None
  • Footnotes
    Support  : NIH Grants EY11766, HL70215, VA Merit Award
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3224. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Modesto Rojas, Tahira Lemtalsi, Haroldo A Toque, Zhimin Xu, Esraa Shosha, David Fulton, R. William Caldwell, Ruth B Caldwell; Blockade of NOX2 or arginase prevents diabetes-induced retinal endothelial cell senescence by restoring NO bioavailability. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3224.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In diabetes, decreased bioavailability of the signaling molecule and endothelial cell (EC) specific vasodilator nitric oxide (NO) plays a major role in EC dysfunction. Diabetes can reduce NO by increasing superoxide (O2.-) which reacts with NO to form peroxynitrite and by increasing the activity of the ureohydrolase enzyme arginase (Arg). Arg competes with NO synthase (NOS) for its substrate L-arginine causing NOS to produce more O2.- and less NO. ROS and decreased NO can cause premature senescence of ECs leading to defective vascular repair. Our previous work has demonstrated the role of the O2.- generating enzyme NOX2, decreased NO and overactive Arg in diabetic retinopathy. Here we investigated the role of ROS, Arg and decreased NO in diabetes-induced EC senescence

Methods : Studies were performed using diabetic wild type and NOX2-/- mice and retinal ECs treated with 25 mM glucose with or without NOX2 blocking peptide gp91phox. Other ECs were treated with H2O2 or the NOS inhibitor L-NAME with or without the NO donor SNAP or the arginase inhibitor ABH. Expression of NOX2 and Arg was assessed by western blot and immunofluorescence. Arginase activity was assayed by measuring urea formation. ROS formation was measured by dihydroethidium and dichlorofluorescein assays. NO formation was measured using chemiluminescence to assay nitrite formation. Cellular senescence was determined by assaying senescence associated β-galactosidase (SA- β-gal) activity

Results : Retinal cells from diabetic mice and high glucose-treated retinal ECs showed significant increases in SA-β-gal activity along with increased ROS formation, elevated Arg activity and expression and decreased NO formation. Deletion of NOX2 or specific blockade of its activity prevented increases in ROS production, normalized arginase activity and expression, restored NO formation and reduced SA-β-gal activity. L-NAME or H2O2 also induced retinal EC senescence which was prevented by treatment with the NO donor or the arginase inhibitor

Conclusions : These results indicate that decreased NO bioavailability accelerates EC senescence. NOX2-generated ROS contribute importantly to diabetes/high glucose induced activation of Arg and decreased NO. Blockade of NOX2 or Arg represents a strategy to prevent diabetes-induced premature EC senescence and promote healthy vascular repair

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×